Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group. 1989

A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
Department of Oncology, Antwerp University Hospital, Belgium.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009588 Nitrogen Mustard Compounds A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. Compounds, Nitrogen Mustard,Mustard Compounds, Nitrogen
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
December 1989, European journal of cancer & clinical oncology,
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
October 1984, European journal of cancer & clinical oncology,
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
December 1986, European journal of cancer & clinical oncology,
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
September 1985, European journal of cancer & clinical oncology,
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
January 1989, Acta oncologica (Stockholm, Sweden),
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
January 1990, European journal of cancer (Oxford, England : 1990),
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
January 1992, European journal of cancer (Oxford, England : 1990),
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
January 1988, Progress in clinical and biological research,
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
January 1998, European urology,
A T van Oosterom, and G Stoter, and A V Bono, and T A Splinter, and S D Fossa, and A J Verbaeys, and P H de Mulder, and M de Pauw, and R Sylvester
April 1999, European urology,
Copied contents to your clipboard!